| Literature DB >> 29743908 |
Małgorzata Ryś1, Tomasz Hryniewiecki1, Ilona Michałowska2, Patrycjusz Stokłosa1, Monika Różewicz-Juraszek1, Zbigniew Chmielak3, Maciej Dąbrowski3, Kryspin Mirota4, Piotr Szymański1.
Abstract
INTRODUCTION: Transcatheter aortic valve implantation (TAVI) improves prognosis in patients disqualified from surgical valve replacement. Calcifications of the aortic complex can lead to deformation of the prosthesis, resulting in paravalvular leaks (PVL). AIM: To evaluate the predictive value of quantitative estimation of volume/weight and geometric distribution of calcifications in multislice computed tomography, for the development of PVL.Entities:
Keywords: aortic regurgitation; aortic stenosis; transcatheter aortic valve implantation
Year: 2018 PMID: 29743908 PMCID: PMC5939549 DOI: 10.5114/aic.2018.74359
Source DB: PubMed Journal: Postepy Kardiol Interwencyjnej ISSN: 1734-9338 Impact factor: 1.426
Figure 1Exemplary reconstruction of aortic valve calcifications. Calcifications located in the aortic valve cusps. There is a variety of calcifications – asymmetric calcifications are visible on the right side and symmetrical distribution on the left side
Demographic, clinical and laboratory characteristics of patients
| Parameter | Study group ( | Control group ( |
|
|---|---|---|---|
| Age [years] | 80.5 ±5.6 | 79.3 ±7.21 | 0.56 |
| Sex (men) | 8 (20%) | 8 (20%) | 1.00 |
| Logistic EuroSCORE (%) | 22.6 ±8.6 | 20.8 ±11.3 | 0.56 |
| Hypertension | 17 (42.5%) | 15 (37.5%) | 0.42 |
| NYHA functional class III | 19 (47.5%) | 19 (47.5%) | 1.00 |
| NYHA functional class IV | 1 (2.5%) | 1 (2.5%) | 1.00 |
| Creatinine [mg/dl] | 120.5 ±72.5 | 103.8 ±30.2 | 0.34 |
| eGFR [ml/min] | 50.3 ±15.9 | 54.3 ±14.3 | 0.41 |
| Diabetes mellitus | 5 (12.5%) | 7 (17.5%) | 0.54 |
| Coronary artery disease | 16 (40%) | 18 (45%) | 0.65 |
Data are presented as the number (%) of patients or mean value ± SD. eGFR – estimated glomerular filtration rate, EuroSCORE – European system for cardiac operative risk evaluation, NYHA – New York Heart Association.
Comparison of echocardiographic findings in cases and controls
| Parameter | Study group ( | Control group ( |
|
|---|---|---|---|
| LVDD [mm] | 51.3 ±8.6 | 46.7 ±7.4 | 0.06 |
| IVS [mm] | 15.7 ±2.2 | 15.6 ±2.2 | 0.79 |
| LVOT [mm] | 21.0 ±2.3 | 19.6 ±1.8 | 0.10 |
| Aortic annulus TTE [mm] | 23.4 ±1.6 | 22 ±1.4 | 0.01 |
| Aortic root [mm] | 35.2 ±4.2 | 32.6 ±1.9 | 0.08 |
| AoGradMax [mm Hg] | 100.0 ±27.3 | 97.6 ±22.8 | 0.76 |
| AoGradMean [mm Hg] | 62.1 ±16 | 60.9 ±17 | 0.96 |
| AVA [cm2] | 0.66 ±0.08 | 0.61 ±0.14 | 0.31 |
| EF (%) | 53.05 ±14.3 | 57.2 ±13 | 0.34 |
Data are presented as the number (%) of patients or mean value ± SD. AVA – aortic valve area, AoGradMax – maximum aortic gradient, AoGradMean – mean aortic gradient, EF – ejection fraction, IVS – interventricular septum, LVDD – left ventricular diastolic diameter, LVOT – left ventricular outflow tract, TTE – transthoracic echocardiography.
Figure 2Aortic valve calcifications in cases and controls. A – Volume of calcifications, B – area of calcification, C – curvature of calcification
Results of univariate modeling of variables predictive of paravalvular leak after TAVI
| Parameter | Odds ratio | 95% Confidence interval |
|
|---|---|---|---|
| Volume [cm3] | 9.032 | < 1.658; 49.203> | 0.011 |
| Area/magnitude [cm2] | 1.227 | <1.056; 1.425> | 0.008 |
| Curvature of calcification [cm3] | 5412.958 | <1.711; 17120823.307> | 0.037 |
| Aortic annulus [mm] | 1.833 | <1.074; 3.130> | 0.026 |